Evidence map›Paper›PMID 37072710›Full record

ReviewBMC infectious diseases2023

A clinical case report of Balamuthia granulomatous amoebic encephalitis in a non-immunocompromised patient and literature review.

Jun Liu, Wenjun Zhang, Shanlian Wu, Tianxiang Zeng, Fei Luo, Qiuhua Jiang, Ruijin Yang

Open access · goldAbstract readReviewCase Reports
In one paragraph

Review in BMC infectious diseases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. The first reported case ofFrontiers in medicine · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Brainstorm: A Case of Granulomatous Encephalitis.Journal of the Association of Medical Microbiology and Infectious Disease Canada = Journal officiel de l'Association pour la microbiologie medicale et l'infectiologie Canada · 2024
    Article
  8. Article
  9. 18F-FDG PET/CT findings in fatalRadiology case reports · 2024
    Article
  10. Phenotypic assay for cytotoxicity assessment ofFrontiers in microbiology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Jun Liu *Department of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Wenjun Zhang *Department of Rehabilitation Medicine, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Shanlian Wu *Department of Pathology, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Tianxiang ZengDepartment of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Fei LuoDepartment of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Qiuhua JiangDepartment of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China.
Ruijin YangDepartment of Neurosurgery, Ganzhou People's Hospital, Ganzhou, 341000, Jiangxi Province, People's Republic of China. yangruijin2007@163.com.
Ganzhou People's Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundBalamuthia granulomatous amoebic encephalitis (GAE) is a peculiar parasitic infectious disease of the central nervous system, about 39% of the infected Balamuthia GAE patients were found to be immunocompromised and is extremely rare clinically. The presence of trophozoites in diseased tissue is an important basis for pathological diagnosis of GAE. Balamuthia GAE is a rare and highly fatal infection for which there is no effective treatment plan in clinical practice. CASE PRESENTATION: This paper reports clinical data from a patient with Balamuthia GAE to improve physician understanding of the disease and diagnostic accuracy of imaging and reduce misdiagnosis. A 61-year-old male poultry farmer presented with moderate swelling pain in the right frontoparietal region without obvious inducement three weeks ago. Head computed tomography(CT) and magnetic resonance imaging(MRI) revealed a space-occupying lesion in the right frontal lobe. Intially clinical imaging diagnosed it as a high-grade astrocytoma. The pathological diagnosis of the lesion was inflammatory granulomatous lesions with extensive necrosis, suggesting amoeba infection. The pathogen detected by metagenomic next-generation sequencing (mNGS) is Balamuthia mandrillaris, the final pathological diagnosis was Balamuthia GAE.

conclusionWhen a head MRI shows irregular or annular enhancement, clinicians should not blindly diagnose common diseases such as brain tumors. Although Balamuthia GAE accounts for only a small proportion of intracranial infections, it should be considered in the differential diagnosis.

Indexed as

AmebiasisCentral Nervous System Parasitic InfectionsCentral Nervous System Protozoal InfectionsEncephalitisInfectious EncephalitisBrainFatal OutcomeGranulomaHumansMaleMiddle AgedBalamuthia mandrillarisEffective antibioticsGranulomatous amoebic encephalitisNon-immunocompromisedSurgical treatment

Identifiers

PMID37072710
PMCPMC10114318
OpenAlexW4366276918

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.